Back to the drawing board: Re-thinking the role of GLI1 in pancreatic carcinogenesis

2Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Aberrant activation of the transcription factor GLI1, a central effector of the Hedgehog (HH) pathway, is associated with several malignancies, including pancreatic ductal adenocarcinoma (PDAC), one of most deadly human cancers. GLI1 has been described as an oncogene in PDAC, making it a promising target for drug therapy. Surprisingly, clinical trials targeting HH/GLI1 axis in advanced PDAC were unsuccessful, leaving investigators questioning the mechanism behind these failures. Recent evidence suggests the loss of GLI1 in the later stages of PDAC may actually accelerate disease. This indicates GLI1 may play a dual role in PDAC, acting as an oncogene in the early stages of disease and a tumor-suppressor in the late stages.

Cite

CITATION STYLE

APA

Hogenson, T. L., Lauth, M., diMagliano, M. P., & Fernandez-Zapico, M. E. (2016). Back to the drawing board: Re-thinking the role of GLI1 in pancreatic carcinogenesis. F1000Research. Faculty of 1000 Ltd. https://doi.org/10.12688/f1000research.5324.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free